Brandon Law, MD, is a board-certified rheumatologist and internist whose clinical interests center on the diagnosis and multidisciplinary management of complex autoimmune disorders including Sjögren’s disease.

In addition to his clinical role, Dr. Law directs early development programs in cellular therapies for autoimmune disease at Bristol Myers Squibb. He is also a member of the Center for Immunology & Inflammatory Diseases at Massachusetts General Hospital.

Dr. Law attended Harvard College, earning his bachelor’s degree in Human Developmental & Regenerative Biology with High Honors, and received his medical degree from Harvard Medical School with Honors in a Special Field through the Harvard–MIT Program in Health Sciences and Technology. He completed his internship, residency, and rheumatology fellowship at Johns Hopkins, where he was also a physician at the Jerome L. Greene Sjögren's Disease Center.

He is the recipient of the J. Mario Molina Physician Scientist Award and the Howard Hughes Medical Institute Medical Research Fellowship. Dr. Law has authored peer-reviewed publications in tissue biology and Sjögren’s disease and has presented his work at the International Symposium on Sjögren’s and American College of Rheumatology.

At Massachusetts General Hospital, Dr. Law served on the faculty at Harvard Medical School, where he led translational research in Sjögren’s disease. He served as principal investigator for a longitudinal registry and biobank in Sjögren’s and as site investigator for Phase III clinical trials evaluating emerging therapies for the disease.

Dr. Law is a member of the American College of Rheumatology and has served on the Consensus Expert Panel for the Sjögren’s Foundation.